Exhibit 99.1 Earnings Release Paysign, Inc. Reports Second Quarter 2024 Financial Results · Second quarter 2024 total revenues of $14.33 million, up 29.8% from second quarter 2023 · Second quarter 2024 net income of $697 thousand, or diluted earnings per share of $0.01, versus net loss of $104 thousand, or diluted earnings per share of $(0.00) for second quarter 2023 · Second quarter 2024 Adjusted EBITDA of $2.24 million, up 95.8% from $1.14 million for second quarter 2023, while diluted Adjusted EBITDA per ...

Paysign, Inc. (NASDAQ:PAYS) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President of Patient Affordability Matt Lanford - Chief Payments Officer Gary Prestopino - Barrington Research Jon Hickman - Ladenburg Thalmann Good afternoon. My name is Kevin, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Paysign Inc. First Quarter 2024 Earnings Conference Call [Operator Instructions]. As a remin ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to __________ Commission file number 001-38623 PAYSIGN, INC. (Exact name of registrant as specified in its charter) Nevada 95-4550154 (Sta ...

Exhibit 99.1 Earnings Release Paysign, Inc. Reports First Quarter 2024 Financial Results · First quarter 2024 total revenues of $13.2 million, up 30% from first quarter 2023 · First quarter 2024 net income of $309 thousand, or diluted earnings per share of $0.01, versus net loss of $160 thousand, or diluted earnings per share of $(0.00) for first quarter 2023 · First quarter 2024 Adjusted EBITDA of $1.7 million, up 135% from $720 thousand for first quarter 2023, while diluted Adjusted EBITDA per share was $ ...

FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐TRANSITION PURSUANT TO UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-38623 PAYSIGN, INC. (Exact name of registrant as specified in its charter) Table of Contents Indicate by check mark whet ...

Okay. If you look at the market, can you size the market for us in terms of -- Jeff Baker That's a great potential revenue. Matt Turner Yes, I'm going to let Jeff answer that one, but I can say that we've kind of discussed this in the past and I think my initial commentary before getting Jeff and Mark to weigh in here would be that every new-to-market drug almost every new-to-market drug, I don't say every but almost every new-to-market drug is going to have some kind of a patient affordability program. So ...

For the Full Year For the Fourth Quarter Adjusted EBITDA and Adjusted EBITDA per share are non-GAAP metrics used by management to gauge the operating performance of the business – see reconciliation of net income to Adjusted EBITDA at the end of the press release. Exhibit 99.1 Earnings Release Paysign, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results 1 · Full-year 2023 total revenues of $47.3 million, up 24% from full-year 2022 · Full-year 2023 net income of $6.5 million, or diluted earnings ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to __________ Commission file number 001-38623 PAYSIGN, INC. (Exact name of registrant as specified in its charter) Nevada 95-4550154 ...

PaySign, Inc. (NASDAQ:PAYS) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Mark Newcomer - Chief Executive Officer Jeff Baker - Chief Financial Officer Conference Call Participants Gary Prestopino - Barrington Research Operator Good afternoon. My name is Kevin, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the PaySign, Inc. Third Quarter 2023 Earnings Conference Call. After the speakerÂ's remarks, there will be a question-and-ans ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to __________ Commission file number 001-38623 PAYSIGN, INC. (Exact name of registrant as specified in its charter) Nevada 95-4550154 (Stat ...